Back
Day Range
$4.37
$4.47
52-Week Range
$1.54
$9.75
Volume
2,298,776
50D / 200D Avg
$5.51
/
$4.59
Prev Close
$4.28
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -7.4 | 0.3 |
| P/B | 5.0 | 3.0 |
| ROE % | -53.2 | 3.7 |
| Net Margin % | -325.3 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$12.40
+183.1%
Low: $10.00
High: $17.00
Forward EPS
-$0.48
Est. Revenue
189.16M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$0.32
$0.26 – $0.39
|
668.41M | 2 |
| FY2029 |
$0.04
$0.03 – $0.04
|
500.96M | 4 |
| FY2028 |
-$0.12
-$0.30 – $0.30
|
406.61M | 6 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-02 | -$0.09 | -$0.11 | -23.6% |
| 2025-11-03 | -$0.17 | -$0.16 | +5.9% |
| 2025-08-07 | -$0.17 | -$0.17 | 0.0% |
| 2025-05-07 | -$0.16 | -$0.16 | 0.0% |
| 2025-03-06 | -$0.14 | -$0.15 | -7.1% |
| 2024-11-06 | -$0.13 | -$0.15 | -15.4% |
| 2024-08-05 | -$0.06 | -$0.15 | -150.0% |
| 2024-05-14 | -$0.08 | -$0.07 | +12.5% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Debt/Equity of 0.03 — conservative balance sheet
Negative free cash flow of -173.78M
PEG of 0.21 suggests growth is underpriced
Capital efficient — spends only 0.56% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)698.96%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-53.18%
ROIC-50.59%
Net Margin-325.31%
Op. Margin-338.72%
Safety
Debt / Equity
0.03
Current Ratio6.95
Interest Coverage-15.57
Valuation
P/E Ratio
-7.42
Forward P/EN/A
P/B Ratio4.97
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 698.96% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 62.90M | Net Income (TTM) | -204.63M |
| ROE | -53.18% | ROA | -34.40% |
| Gross Margin | 86.58% | Operating Margin | -338.72% |
| Net Margin | -325.31% | Free Cash Flow (TTM) | -173.78M |
| ROIC | -50.59% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.03 | Current Ratio | 6.95 |
| Interest Coverage | -15.57 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -7.42 | Forward P/E | N/A |
| P/B Ratio | 4.97 | P/S Ratio | 24.13 |
| PEG Ratio | 0.21 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | 36.06 |
| Forward P/S | 8.03 | Fwd Earnings Yield | N/A |
| FCF Yield | -11.45% | ||
| Market Cap | 1.52B | Enterprise Value | 1.36B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 62.90M | 7.87M | 0.0 | 0.0 | 0.0 |
| Net Income | -204.63M | -567.94M | -75.80M | -104.20M | -86.85M |
| EPS (Diluted) | -0.60 | -2.11 | -0.35 | -0.48 | -0.44 |
| Gross Profit | 54.46M | 795,000.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -213.06M | -592.63M | -99.82M | -119.73M | -93.32M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 594.82M | 540.63M | 621.48M | 672.14M | 776.15M |
| Total Liabilities | 289.11M | 76.84M | 16.36M | 17.07M | 30.15M |
| Shareholders' Equity | 305.72M | 463.79M | 605.12M | 655.08M | 746.00M |
| Total Debt | 10.15M | 8.92M | 4.01M | 4.26M | 3.06M |
| Cash & Equivalents | 164.09M | 35.72M | 42.65M | 101.10M | 132.42M |
| Current Assets | 571.52M | 526.26M | 616.43M | 667.32M | 772.07M |
| Current Liabilities | 82.23M | 58.24M | 13.97M | 13.16M | 16.93M |